Trademark: 88340770
Status Date
Monday, February 27, 2023
Filing Date
Thursday, March 14, 2019
Published for Opposition
Tuesday, November 26, 2019
Abandoned Date
Monday, February 27, 2023
44 Medical stem cell therapy services; stem cell therapy services; medical services; providing medical information, consultancy and advisory services; medical services in the field of cell therapies and immunology; medical radiology services; providing medical information, namely, reporting of consumer authorized clinical testing results regarding genetics and disease prediction directly to the patient; providing medical information in the field of genetics disease diagnosis and prognosis; providing medical information in the field of predicting genetics disease and treating genetic diseases; providing medical information to medical professionals and patients in the form of reports in the fields of genetics and genetic diseases; Medical data analysis services for diagnostic and treatment purposes provided by medical laboratories in the fields of genetics and genetic disease prediction; Medical diagnostic reporting services in the fields of genetics and genetic disease prediction; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the fields of genetics and genetic diseases; Medical testing for diagnostic and treatment purposes in the field of genetic diseases; Medical analysis services, namely, conducting medical diagnostic testing to determine risk factors for diseases; medical analysis services for diagnostic and treatment purposes provided by medical laboratories
42 Providing information in the nature of measurement evaluations and laboratory analysis in the fields of genetics, disease prediction and genetic disease treatment assessments; Data analysis in the fields of genetics, disease prediction and genetic disease treatment assessments for medical research purposes; Platform as a service (PAAS) featuring computer software platforms for predictive analytics in the field of genetics, disease prediction and treatment assessments; Software as a service (SAAS) services featuring software for machine learning in the fields of genetics, disease prediction and genetic disease treatment assessments; Providing temporary use of non-downloadable computer software for testing, data analysis, diagnosis, prognosis, reporting, and monitoring in the field of genetics, disease prediction and genetic disease treatment assessments; Platform as a service (PAAS) featuring computer software platforms for use in testing, data analysis, diagnosis, prognosis, reporting, and monitoring in the field of genetics, disease prediction and genetic disease treatment assessments; Web based non-downloadable software for machine learning, deep learning, and artificial intelligence in the field of genetics, disease prediction and genetic disease treatment assessments; Providing medical testing services in the field of genetic disease prediction and treatment for medical research purposes; medical laboratory services; medical laboratories; medical therapeutics research services, namely, computational genetics services in the nature of DNA testing and analysis for medical research purposes
PRECISION AUTO LOGY
"AUTOLOGY"
Feb 27, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Feb 27, 2023
Abandonment - No Use Statement Filed
Aug 6, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2022
Sou Extension 5 Granted
Jul 18, 2022
Sou Extension 5 Filed
Aug 5, 2022
Case Assigned To Intent To Use Paralegal
Jul 18, 2022
Teas Extension Received
Jan 20, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 18, 2022
Sou Extension 4 Granted
Jan 18, 2022
Sou Extension 4 Filed
Jan 18, 2022
Teas Extension Received
Jul 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Jul 14, 2021
Sou Extension 3 Granted
Jul 14, 2021
Sou Extension 3 Filed
Jul 14, 2021
Teas Extension Received
Mar 19, 2021
Assigned To Examiner
Jan 16, 2021
Notice Of Approval Of Extension Request E-Mailed
Jan 14, 2021
Sou Extension 2 Granted
Jan 14, 2021
Sou Extension 2 Filed
Jan 14, 2021
Teas Extension Received
Jul 22, 2020
Notice Of Approval Of Extension Request E-Mailed
Jul 20, 2020
Sou Extension 1 Granted
Jul 20, 2020
Sou Extension 1 Filed
Jul 20, 2020
Teas Extension Received
Jan 21, 2020
Noa E-Mailed - Sou Required From Applicant
Nov 26, 2019
Official Gazette Publication Confirmation E-Mailed
Nov 26, 2019
Published For Opposition
Nov 6, 2019
Notification Of Notice Of Publication E-Mailed
Oct 21, 2019
Approved For Pub - Principal Register
Oct 17, 2019
Examiner's Amendment Entered
Oct 17, 2019
Notification Of Examiners Amendment E-Mailed
Oct 17, 2019
Examiners Amendment E-Mailed
Oct 17, 2019
Examiners Amendment -Written
Oct 15, 2019
Notification Of Priority Action E-Mailed
Oct 15, 2019
Priority Action E-Mailed
Oct 15, 2019
Priority Action Written
Sep 16, 2019
Teas/Email Correspondence Entered
Sep 13, 2019
Correspondence Received In Law Office
Sep 13, 2019
Teas Response To Office Action Received
Aug 7, 2019
Notification Of Non-Final Action E-Mailed
Aug 7, 2019
Non-Final Action E-Mailed
Aug 7, 2019
Non-Final Action Written
Jul 18, 2019
Teas/Email Correspondence Entered
Jul 18, 2019
Correspondence Received In Law Office
Jul 14, 2019
Assigned To Lie
Jul 9, 2019
Teas Response To Office Action Received
May 30, 2019
Notification Of Non-Final Action E-Mailed
May 30, 2019
Non-Final Action E-Mailed
May 30, 2019
Non-Final Action Written
May 23, 2019
Assigned To Examiner
Apr 2, 2019
New Application Office Supplied Data Entered
Mar 18, 2019
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
